Skip to main content
Log in

Failure of beta interferon therapy in X-linked adrenoleukodystrophy

  • Letters to the Editors
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abbreviations

ALD :

adrenoleukodystrophy

cALD :

cerebral ALD

INFB :

beta interferon

VLCFA :

very long chain fatty acids

References

  1. FNB Multiple Sclerosis Study Group (1993) Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. Neurology 43: 655–661

    Google Scholar 

  2. Powers JM, Liu Y, Moser A, Moser H (1990) The inflammatory myelinopathy of adreno-leukodystrophy: cells, effector molecules, and pathogenetic implications. J Neuropathol Exp Neurol 51: 630–643

    Google Scholar 

  3. Stone LA, Frank JA, Albert PS et al. (1995) The effect of interferon beta on blood brain barrier disruptions demonstrated by contrast enhanced magnetic resonance imaging in relapsing remitting multiple sclerosis. Ann Neurol 37:611–619

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Korenke, G.C., Christen, H.J., Hunneman, D.H. et al. Failure of beta interferon therapy in X-linked adrenoleukodystrophy. Eur J Pediatr 155, 833 (1996). https://doi.org/10.1007/BF02002922

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02002922

Keywords

Navigation